help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salani, D.
Right arrow Articles by Bagnato, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salani, D.
Right arrow Articles by Bagnato, A.
(American Journal of Pathology. 2000;157:1537-1547.)
© 2000 American Society for Investigative Pathology

Regular Articles

Role of Endothelin-1 in Neovascularization of Ovarian Carcinoma

Debora Salani*, Valeriana Di Castro*, Maria Rita Nicotra§, Laura Rosanò*, Raffaele Tecce*, Aldo Venuti{ddagger}, Pier Giorgio Natali{dagger} and Anna Bagnato*

From the Laboratories of Molecular Pathology and Ultrastructure,*
Immunology,{dagger}
and Virology,{ddagger}
Regina Elena Cancer Institute; and the Biotechnology Institute,§
Consiglio Nazionale delle Ricerche, Rome, Italy

Endothelin-1 (ET-1) is overexpressed in ovarian carcinomas and acts, via ETA receptors (ETAR), as an autocrine growth factor. In this study we investigate the role of ET-1 in the neovascularization of ovarian carcinoma. Archival specimens of primary (n = 40) and metastatic (n = 8) ovarian tumors were examined by immunohistochemistry for angiogenic factor and receptor expression and for microvessel density using antibodies against CD31, ET-1, vascular endothelial growth factor (VEGF), and their receptors. ET-1 expression correlated with neovascularization and with VEGF expression. The localization of functional ETAR and ETAR mRNA expression, as detected by autoradiography and in situ hybridization, was evident in tumors and in intratumoral vessels, whereas ETBR were expressed mainly in endothelial cells. High levels of ET-1 were detected in the majority of ascitic fluids of patients with ovarian carcinoma and significantly correlated with VEGF ascitic concentration. Furthermore ET-1, through ETAR, stimulated VEGF production in an ovarian carcinoma cell line, OVCA 433, by an extent comparable to hypoxia. Finally, conditioned media from OVCA 433 as well as ascitic fluids caused an increase in endothelial cell migration and the ET-1 receptor blockade significantly inhibited this angiogenic response. These findings indicate that ET-1 could modulate tumor angiogenesis, acting directly and in part through VEGF.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
K. Lange, M. Kammerer, M. E. Hegi, S. Grotegut, A. Dittmann, W. Huang, E. Fluri, G. W. Yip, M. Gotte, C. Ruiz, et al.
Endothelin Receptor Type B Counteracts Tenascin-C-Induced Endothelin Receptor Type A-Dependent Focal Adhesion and Actin Stress Fiber Disorganization
Cancer Res., July 1, 2007; 67(13): 6163 - 6173.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Rosano, V. Di Castro, F. Spinella, G. Tortora, M. R. Nicotra, P. G. Natali, and A. Bagnato
Combined Targeting of Endothelin A Receptor and Epidermal Growth Factor Receptor in Ovarian Cancer Shows Enhanced Antitumor Activity
Cancer Res., July 1, 2007; 67(13): 6351 - 6359.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Rosano, V. Di Castro, F. Spinella, M. R. Nicotra, P. G. Natali, and A. Bagnato
ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo
Mol. Cancer Ther., July 1, 2007; 6(7): 2003 - 2011.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
M J Grimshaw
Endothelins and hypoxia-inducible factor in cancer
Endocr. Relat. Cancer, June 1, 2007; 14(2): 233 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer
Nonclassic Endogenous Novel Regulators of Angiogenesis
Pharmacol. Rev., June 1, 2007; 59(2): 185 - 205.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C. N. Mowa, S. Maeda, Y. Hattori, and T. Miyauchi
Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts
Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1030 - E1040.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Spinella, L. Rosano, V. Di Castro, S. Decandia, M. R. Nicotra, P. G. Natali, and A. Bagnato
Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1{alpha} in Human Melanoma Cells
Cancer Res., February 15, 2007; 67(4): 1725 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B.-Y. Bao, J. Yao, and Y.-F. Lee
1{alpha}, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis
Carcinogenesis, September 1, 2006; 27(9): 1883 - 1893.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
F. Spinella, L. Rosano, S. Decandia, V. Di Castro, A. Albini, G. Elia, P. G. Natali, and A. Bagnato
Antitumor Effect of Green Tea Polyphenol Epigallocatechin-3-Gallate in Ovarian Carcinoma Cells: Evidence for the Endothelin-1 as a Potential Target.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1123 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
L. Rosano, F. Spinella, V. Di Castro, S. Decandia, M. R. Nicotra, P. G. Natali, and A. Bagnato
Endothelin-1 Is Required During Epithelial to Mesenchymal Transition in Ovarian Cancer Progression.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1128 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
L. Rosano, V. Di Castro, F. Spinella, S. Decandia, P. G. Natali, and A. Bagnato
ZD4054, a Potent Endothelin Receptor A Antagonist, Inhibits Ovarian Carcinoma Cell Proliferation.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1132 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
F. Spinella, L. Rosano, V. Di Castro, S. Decandia, A. Albini, M. R. Nicotra, P. G. Natali, and A. Bagnato
Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
Mol. Cancer Ther., June 1, 2006; 5(6): 1483 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Rosano, F. Spinella, V. Di Castro, S. Dedhar, M. R. Nicotra, P. G. Natali, and A. Bagnato
Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.
Mol. Cancer Ther., April 1, 2006; 5(4): 833 - 842.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Rosano, F. Spinella, V. Di Castro, M. R. Nicotra, S. Dedhar, A. G. de Herreros, P. G. Natali, and A. Bagnato
Endothelin-1 Promotes Epithelial-to-Mesenchymal Transition in Human Ovarian Cancer Cells
Cancer Res., December 15, 2005; 65(24): 11649 - 11657.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Bagnato, F. Spinella, and L. Rosano
Emerging role of the endothelin axis in ovarian tumor progression
Endocr. Relat. Cancer, December 1, 2005; 12(4): 761 - 772.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
V. L. M. Herrera, L. R. B. Ponce, P. D. Bagamasbad, B. D. VanPelt, T. Didishvili, and N. Ruiz-Opazo
Embryonic lethality in Dear gene-deficient mice: new player in angiogenesis
Physiol Genomics, November 17, 2005; 23(3): 257 - 268.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Kajiyama, K. Shibata, M. Terauchi, T. Morita, K. Ino, S. Mizutani, and F. Kikkawa
Neutral Endopeptidase 24.11/CD10 Suppresses Progressive Potential in Ovarian Carcinoma In vitro and In vivo
Clin. Cancer Res., March 1, 2005; 11(5): 1798 - 1808.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Lahav, M.-L. Suva, D. Rimoldi, P. H. Patterson, and I. Stamenkovic
Endothelin Receptor B Inhibition Triggers Apoptosis and Enhances Angiogenesis in Melanomas
Cancer Res., December 15, 2004; 64(24): 8945 - 8953.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Spinella, L. Rosano, V. Di Castro, P. G. Natali, and A. Bagnato
Endothelin-1-induced Prostaglandin E2-EP2, EP4 Signaling Regulates Vascular Endothelial Growth Factor Production and Ovarian Carcinoma Cell Invasion
J. Biol. Chem., November 5, 2004; 279(45): 46700 - 46705.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Spinella, L. Rosano, V. Di Castro, M. R. Nicotra, P. G. Natali, and A. Bagnato
Inhibition of Cyclooxygenase-1 and -2 Expression by Targeting the Endothelin A Receptor in Human Ovarian Carcinoma Cells
Clin. Cancer Res., July 15, 2004; 10(14): 4670 - 4679.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Wulfing, C. Kersting, J. Tio, R.-J. Fischer, C. Wulfing, C. Poremba, R. Diallo, W. Bocker, and L. Kiesel
Endothelin-1-, Endothelin-A-, and Endothelin-B-Receptor Expression Is Correlated with Vascular Endothelial Growth Factor Expression and Angiogenesis in Breast Cancer
Clin. Cancer Res., April 1, 2004; 10(7): 2393 - 2400.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Spinella, L. Rosano, V. Di Castro, M. R. Nicotra, P. G. Natali, and A. Bagnato
Endothelin-1 Decreases Gap Junctional Intercellular Communication by Inducing Phosphorylation of Connexin 43 in Human Ovarian Carcinoma Cells
J. Biol. Chem., October 17, 2003; 278(42): 41294 - 41301.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. J. Yin, K. S. Mohammad, S. M. Kakonen, S. Harris, J. R. Wu-Wong, J. L. Wessale, R. J. Padley, I. R. Garrett, J. M. Chirgwin, and T. A. Guise
From the Cover: A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
PNAS, September 16, 2003; 100(19): 10954 - 10959.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Wulfing, R. Diallo, C. Kersting, C. Wulfing, C. Poremba, A. Rody, R. R. Greb, W. Bocker, and L. Kiesel
Expression of Endothelin-1, Endothelin-A, and Endothelin-B Receptor in Human Breast Cancer and Correlation with Long-Term Follow-Up
Clin. Cancer Res., September 15, 2003; 9(11): 4125 - 4131.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Rosano, F. Spinella, V. Di Castro, M. R. Nicotra, A. Albini, P. G. Natali, and A. Bagnato
Endothelin Receptor Blockade Inhibits Molecular Effectors of Kaposi's Sarcoma Cell Invasion and Tumor Growth in Vivo
Am. J. Pathol., August 1, 2003; 163(2): 753 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. A. Zonnenberg, G. Groenewegen, T. J. Janus, T. W. Leahy, R. A. Humerickhouse, J. D. Isaacson, R. A. Carr, and E. Voest
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Atrasentan: An Endothelin Receptor Antagonist for Refractory Prostate Cancer
Clin. Cancer Res., August 1, 2003; 9(8): 2965 - 2972.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Rosano, F. Spinella, D. Salani, V. Di Castro, A. Venuti, M. R. Nicotra, P. G. Natali, and A. Bagnato
Therapeutic Targeting of the Endothelin A Receptor in Human Ovarian Carcinoma
Cancer Res., May 15, 2003; 63(10): 2447 - 2453.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Pikkarainen, H. Tokola, R. Kerkela, T. Majalahti-Palviainen, O. Vuolteenaho, and H. Ruskoaho
Endothelin-1-specific Activation of B-type Natriuretic Peptide Gene via p38 Mitogen-activated Protein Kinase and Nuclear ETS Factors
J. Biol. Chem., January 31, 2003; 278(6): 3969 - 3975.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Bagnato, A. Cirilli, D. Salani, P. Simeone, A. Muller, M. R. Nicotra, P. G. Natali, and A. Venuti
Growth Inhibition of Cervix Carcinoma Cells in Vivo by Endothelin A Receptor Blockade
Cancer Res., November 15, 2002; 62(22): 6381 - 6384.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Favier, P.-F. Plouin, P. Corvol, and J.-M. Gasc
Angiogenesis and Vascular Architecture in Pheochromocytomas : Distinctive Traits in Malignant Tumors
Am. J. Pathol., October 1, 2002; 161(4): 1235 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Spinella, L. Rosano, V. Di Castro, P. G. Natali, and A. Bagnato
Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1alpha in Ovarian Carcinoma Cells
J. Biol. Chem., July 26, 2002; 277(31): 27850 - 27855.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Herrmann, P. J. Best, E. L. Ritman, D. R. Holmes Jr, L. O. Lerman, and A. Lerman
Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia
J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1555 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Del Bufalo, V. Di Castro, A. Biroccio, M. Varmi, D. Salani, L. Rosano, D. Trisciuoglio, F. Spinella, and A. Bagnato
Endothelin-1 Protects Ovarian Carcinoma Cells against Paclitaxel-Induced Apoptosis: Requirement for Akt Activation
Mol. Pharmacol., March 1, 2002; 61(3): 524 - 532.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Rosano, M. Varmi, D. Salani, V. Di Castro, F. Spinella, P. Giorgio Natali, and A. Bagnato
Endothelin-1 Induces Tumor Proteinase Activation and Invasiveness of Ovarian Carcinoma Cells
Cancer Res., November 1, 2001; 61(22): 8340 - 8346.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Bagnato, L. Rosano, V. Di Castro, A. Albini, D. Salani, M. Varmi, M. R. Nicotra, and P. G. Natali
Endothelin Receptor Blockade Inhibits Proliferation of Kaposi's Sarcoma Cells
Am. J. Pathol., March 1, 2001; 158(3): 841 - 847.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Salani, G. Taraboletti, L. Rosano, V. Di Castro, P. Borsotti, R. Giavazzi, and A. Bagnato
Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo
Am. J. Pathol., November 1, 2000; 157(5): 1703 - 1711.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.